Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 22, 2017
Pharmacy Choice - News - Pharmaceutical Development - May 22, 2017

Pharmacy News

 Pharmaceutical Development
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/15/17 - "Recombinant Human Epo-Fc Fusion Proteins with Prolonged Half-Life and Enhanced Erythropoietic Activity in Vivo" in Patent Application Approval...
"Recombinant Human Epo-Fc Fusion Proteins with Prolonged Half-Life and Enhanced Erythropoietic Activity in Vivo" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Wang, Haitao; Du, Yong; Zhang, Rui; Xu, Jing; Liu, Longbin, filed on June 27, 2016, was made ava
5/15/17 - 'Outstanding' results announced from new blood cancer study
-Professor Martin Dyer, University of Leicester. The advance led by a team from the University of Leicester and University Hospitals of Leicester NHS Trust, within the Hope Clinical Trials Facility, focused on treating patients with CLL. The study opened in January 2012 and 90 patients were enrolled in different centres in the UK and in France, wit
5/15/17 - A transplant and a cure: Penn team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors
By a News Reporter-Staff News Editor at Pharma Business Week CHICAGO Ten patients at Penn Medicine have been cured of the Hepatitis C virus following lifesaving kidney transplants from deceased donors who were infected with the disease. Early data from the study were presented today by David S. Goldberg, MD, MSCE, an assistant professor of Medi
5/15/17 - AbbVie Demonstrates Leadership in Gastroenterology and Hepatology with New Data and Late-Breaking Studies to be Presented at Digestive Disease Week
By a News Reporter-Staff News Editor at Clinical Trials Week- AbbVie, a global biopharmaceutical company, announced that data from 20 abstracts in gastroenterology and hepatology programs will be presented at Digestive Disease Week 2017, May 6- 9, in Chicago. "AbbVie's research presented at DDW this year represents our commitment to developin
5/15/17 - Acorda to Present at the Deutsche Bank 42nd Annual Healthcare Conference
By a News Reporter-Staff News Editor at Pharma Business Week Acorda Therapeutics, Inc. will present at the Deutsche Bank 42nd Annual Healthcare Conference in Boston on Thursday, May 4, 2017 at 11:20 a.m. EDT. About Acorda Therapeutics Founded in 1995, Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore.
5/15/17 - Aerie Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update
By a News Reporter-Staff News Editor at Clinical Trials Week Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, reported financial results for the first quarter ended
5/15/17 - Aeterna Zentaris Announces that ZoptEC Phase 3 Clinical Study of Zoptrex? Did Not Achieve its Primary Endpoint
By a News Reporter-Staff News Editor at Clinical Trials Week Aeterna Zentaris Inc. announced that the ZoptEC Phase 3 clinical study of Zoptrex? in women with locally advanced, recurrent or metastatic endometrial cancer did not achieve its primary endpoint of demonstrating a statistically significant increase in the median period of overall surv
5/15/17 - Alkermes Announces Completion of Patient Enrollment in Pivotal Antipsychotic Efficacy Study of ALKS 3831 for Schizophrenia
By a News Reporter-Staff News Editor at Mental Health Weekly Digest Alkermes plc announced completion of patient enrollment in ENLIGHTEN-1, the first of two key phase 3 studies in the ENLIGHTEN clinical development program for ALKS 3831, an investigational, novel, once-daily, oral atypical antipsychotic drug candidate for the treatment of schizop
5/15/17 - Altor BioScience Corporation Announces FDA Fast Track Designation for Lead Candidate ALT-803 in Patients with Non-Muscle Invasive Bladder Cancer
By a News Reporter-Staff News Editor at Cancer Vaccine Week Altor BioScience Corporation, a leading developer of novel cytokine-based immunotherapeutics for cancer and infectious diseases, announced that it has received Fast Track designation from the U.S. Food and Drug Administration for its investigational interleukin-15 agonist complex, ALT-80
5/15/17 - Aptar Pharma Partners with Kali Care to Develop Real-Time Medication Management Technology
By a News Reporter-Staff News Editor at Clinical Trials Week Aptar Pharma and Kali Care have announced that they entered into a partnership in order to address the challenge of monitoring adherence in ophthalmic clinical trials. Kali Care, a Silicon Valley- based technology company, provides a revolutionary sensor technology which allows clinicia
5/15/17 - Arqule Reports First Quarter 2017 Financial Results
By a News Reporter-Staff News Editor at Clinical Trials Week ArQule, Inc. announced its financial results for the first quarter of 2017. For the quarter ended March 31, 2017, the Company reported a net loss of $7,576,000 or $0.11 per share, compared with net loss of $4,981,000 or $0.08 per share, for the quarter ended March 31, 2016. At March 31,
5/15/17 - AstraZeneca's stock price up sharply after positive results for lung, bladder cancer drug
AstraZeneca and MedImmune, its global biologics research and development arm reported positive results when using Imfinzifor the Phase III PACIFIC trial for some patients with Phase III lung cancer. AstraZeneca plans to submit the initial results from the PACIFIC trial for presentation at a forthcoming medical meeting. Sean Bohen, executive vice...
5/15/17 - Athersys Partnering With MedCision on High-Volume ThawSTAR Cell Thawing Systems for Use in Clinical Trials
By a News Reporter-Staff News Editor at Clinical Trials Week MedCision, LLC., the world leader in the automation of cell thawing, and Athersys, Inc., a clinical-stage biotechnology company developing proprietary cell therapies, have formed a strategic partnership to include the use of the ThawSTAR Cell Thawing System in Athersys' clinical tria
5/15/17 - Baxter Achieves Regulatory Milestone for New Peritoneal Dialysis Technology
By a News Reporter-Staff News Editor at Clinical Trials Week Baxter International Inc., a global innovator in renal care, received guidance from the U.S. Food and Drug Administration clarifying the regulatory pathway for an innovative, home peritoneal dialysis solution system to improve patient access to home dialysis. Following FDA guidance, Bax
5/15/17 - Bio Pharma Services, Inc. Completes Another Successful Inspection by the European Medicines Agency EMA
By a News Reporter-Staff News Editor at Clinical Trials Week Bio Pharma Services, Inc. ended their 10th year anniversary celebrations by announcing the successful EMA inspection of their Toronto based clinical and bioanalytical site. Bio Pharma's outstanding regulatory history includes successful inspections by the US FDA, UK MHRA, Health Canada,
5/15/17 - BioDelivery Sciences Announces the Approval of BUNAVAIL for Induction of Buprenorphine Treatment for Opioid Dependence
By a News Reporter-Staff News Editor at Pharma Business Week- BioDelivery Sciences International, Inc. announced that the U.S. Food and Drug Administration has approved a Supplemental New Drug Application for BUNAVAIL buccal film revising the indication to include the use of BUNAVAIL for the initiation of buprenorphine treatment for opioid...
5/15/17 - Biohaven's Trigriluzole Receives Fast Track Designation From U.S. FDA
Biohaven Pharmaceutical Holding Company Ltd. announced today that the U.S. Food and Drug Administration has granted the company Fast Track Designation for Biohaven's product candidate trigriluzole for the potential treatment of Spinocerebellar Ataxia. Trigriluzole previously received Orphan Drug Designation from the FDA for the treatment of SCA
5/15/17 - Bonti Announces Hot Topics Presentation of Phase 2a Interim Clinical Data at The Aesthetic Meeting 2017
By a News Reporter-Staff News Editor at Clinical Trials Week Bonti, a privately-held, clinical-stage biotechnology company, announced the debut presentation of interim clinical data from Phase 2 study EB-001-GL201 of EB-001 in subjects with glabellar lines. Steve Yoelin, a co-principal investigator of the study, led off the highly attended Premie
5/15/17 - Braeburn Pharmaceuticals and Camurus Announce Positive Top-line Results from Long-term Phase 3 Safety Study of CAM2038
By a News Reporter-Staff News Editor at Clinical Trials Week- Braeburn Pharmaceuticals and Camurus announced positive top-line results from a long-term Phase 3 trial supporting the safety and efficacy of CAM2038 in patients with moderate-to-severe opioid use disorder. "The positive results from this study, coupled with the earlier reported posit
5/15/17 - Cerveau Technologies, Inc. Signs Clinical Supply Agreement with Merck for Investigational Tau Imaging Agent
By a News Reporter-Staff News Editor at Clinical Trials Week Cerveau Technologies, Inc. announced finalization of a clinical supply agreement with Merck, known as MSD outside the US and Canada, providing access to an investigational imaging agent being evaluated in Positron Emission Tomography scans for assessing the status and progression of...
5/15/17 - China FDA Approves Country's First All-Oral Regimen for Chronic Hepatitis C, Daklinza daclatasvir in Combination with Sunvepra asunaprevir
By a News Reporter-Staff News Editor at Clinical Trials Week Bristol-Myers Squibb Company announced that the China Food and Drug Administration has approved a direct-acting antiviral regimen comprised of Daklinza and Sunvepra , for the treatment of treatment-naive or- experienced patients, with or without compensated cirrhosis, infected with
5/15/17 - Collagenase SANTYL Ointment advances pressure ulcers through the healing process faster, new study suggests
By a News Reporter-Staff News Editor at Clinical Trials Week- Smith& Nephew, the global medical technology business, welcomes the publication of a new research paper showing how pressure ulcers, when treated with Collagenase SANTYL Ointment, achieve faster rates of granulation and epithelialization when compared against medicinal honey treatment.
5/15/17 - Concert Pharmaceuticals Initiates CTP-543 Phase 2 Trial in Alopecia Areata
By a News Reporter-Staff News Editor at Clinical Trials Week Concert Pharmaceuticals, Inc. announced the initiation of a Phase 2 a clinical trial evaluating CTP-543 for the treatment of moderate-to-severe alopecia areata, an autoimmune disorder in which the immune system attacks hair follicles, resulting in patchy or complete hair loss.
5/15/17 - Data on Colon Cancer Reported by Researchers at Edogawa Hospital (Response to regorafenib at an initial dose of 120 mg as salvage therapy for...
Data on Colon Cancer Reported by Researchers at Edogawa Hospital. By a News Reporter-Staff News Editor at Clinical Trials Week New research on Oncology- Colon Cancer is the subject of a report. Our news journalists obtained a quote from the research from Edogawa Hospital, "The objective of this study was to retrospectively evaluate the clinical b
5/15/17 - Disfiguring eye symptoms diminish in Graves' eye disease drug trial
By a News Reporter-Staff News Editor at Clinical Trials Week ANN ARBOR, Mich.- The disease is characterized by inflammation and a buildup of tissue around the eyes that cause them to bulge painfully from their sockets. The results of a clinical trial led by the University of Michigan Kellogg Eye Center offers hope for those with moderate-to-sever
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415